{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T08:12:11Z","timestamp":1698739931237},"reference-count":34,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2013,6,19]],"date-time":"2013-06-19T00:00:00Z","timestamp":1371600000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Andrology"],"published-print":{"date-parts":[[2013,7]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Udenafil is a potent phosphodiesterase type\u20105 inhibitor (<jats:styled-content style=\"fixed-case\">PDE<\/jats:styled-content>5) previously shown in studies conducted in populations of Eastern\u2010Asian ethnicity, to significantly improve sexual function, in addition to a favourable safety profile. The purpose of this study was to evaluate the efficacy and safety of udenafil for the treatment of erectile dysfunction (ED), for the first time in a non\u2010Eastern\u2010Asian population. In this multicentre, randomized, double\u2010blind, parallel, placebo\u2010controlled study conducted in five centres in Turkey, 118 eligible subjects were randomized to receive udenafil 100\u00a0mg taken as on\u2010demand or matching placebo for an 8\u2010week treatment period. The primary efficacy variable was the change from baseline of the International Index of Erectile Function Questionnaire\u2013Erectile Function Domain (<jats:styled-content style=\"fixed-case\">IIEF<\/jats:styled-content>\u2013<jats:styled-content style=\"fixed-case\">EFD<\/jats:styled-content>) score, secondary efficacy variables were changes from baseline in <jats:styled-content style=\"fixed-case\">IIEF<\/jats:styled-content> Questionnaire Domains' 2\u20135 scores (Intercourse Satisfaction, Orgasmic Function, Sexual Desire, Overall Sexual Satisfaction) and <jats:styled-content style=\"fixed-case\">IIEF<\/jats:styled-content> Questionnaire Grand Total score, changes from baseline in penetration success rates (<jats:styled-content style=\"fixed-case\">SEP<\/jats:styled-content>2) and intercourse completion rates (<jats:styled-content style=\"fixed-case\">SEP<\/jats:styled-content>3) and evaluation of responses to the global assessment question (<jats:styled-content style=\"fixed-case\">GAQ<\/jats:styled-content>). Patients treated with udenafil demonstrated significantly higher increase in the <jats:styled-content style=\"fixed-case\">IIEF<\/jats:styled-content>\u2013<jats:styled-content style=\"fixed-case\">EFD<\/jats:styled-content> scores compared with placebo\u2010treated subjects [4.0 (95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>: 1.3\u20136.6; <jats:italic>p<\/jats:italic>\u00a0=\u00a00.003)]. Similarly, greater improvements were observed in the scores for <jats:styled-content style=\"fixed-case\">SEP<\/jats:styled-content>2 [0.65 (95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>: 0.02\u20131.3, <jats:italic>p<\/jats:italic>\u00a0=\u00a00.043)], <jats:styled-content style=\"fixed-case\">SEP<\/jats:styled-content>3 [0.9 (95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>: 0.3\u20131.5, <jats:italic>p<\/jats:italic>\u00a0=\u00a00.003)] and two other <jats:styled-content style=\"fixed-case\">IIEF<\/jats:styled-content> Questionnaire Domains (Domain 4: Sexual Desire, Domain 5: Overall Sexual Satisfaction). The proportion of positive responses to the <jats:styled-content style=\"fixed-case\">GAQ<\/jats:styled-content> was greater in the udenafil compared to the placebo group (72.2% vs. 49.1%, <jats:italic>p<\/jats:italic>\u00a0=\u00a00.014). The most frequent treatment\u2010emergent adverse events were headache, flushing and rhinorrhea, all of mild or moderate severity. This is the first study to demonstrate in a non\u2010Eastern\u2010Asian population that udenafil 100\u00a0mg taken as on\u2010demand can effectively improve erectile function and is well tolerated.<\/jats:p>","DOI":"10.1111\/j.2047-2927.2013.00085.x","type":"journal-article","created":{"date-parts":[[2013,6,20]],"date-time":"2013-06-20T01:27:47Z","timestamp":1371691667000},"page":"549-555","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Efficacy and tolerability of udenafil in Turkish men with erectile dysfunction of psychogenic and organic aetiology: a randomized, double\u2010blind, placebo\u2010controlled study"],"prefix":"10.1111","volume":"1","author":[{"given":"M.","family":"Orta\u00e7","sequence":"first","affiliation":[{"name":"Department of Urology Istanbul Faculty of Medicine Istanbul University Istanbul"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"\u00c7ayan","sequence":"additional","affiliation":[{"name":"Department of Urology University of Mersin School of Medicine Mersin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. K.","family":"\u00c7al\u0131\u015fkan","sequence":"additional","affiliation":[{"name":"Department of Urology University of Mersin School of Medicine Mersin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. \u00d6.","family":"Yaman","sequence":"additional","affiliation":[{"name":"Department of Urology Ankara University School of Medicine Ankara"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. M.","family":"Okutucu","sequence":"additional","affiliation":[{"name":"Department of Urology Ankara University School of Medicine Ankara"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. B.","family":"Semerci","sequence":"additional","affiliation":[{"name":"Department of Urology Ege University School of Medicine Izmir"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. B.","family":"Altay","sequence":"additional","affiliation":[{"name":"Department of Urology Ege University School of Medicine Izmir"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. D.","family":"Balbay","sequence":"additional","affiliation":[{"name":"Urology Clinics Ankara Ataturk Training &amp; Research Hospital Ankara Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. F.","family":"\u00d6zcan","sequence":"additional","affiliation":[{"name":"Urology Clinics Ankara Ataturk Training &amp; Research Hospital Ankara Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Kad\u0131o\u011flu","sequence":"additional","affiliation":[{"name":"Department of Urology Istanbul Faculty of Medicine Istanbul University Istanbul"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,6,19]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0302-2838(02)00027-1"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2010.01882.x"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2011.02506.x"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410x.1999.00142.x"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543776.2011.614435"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(99)00099-0"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2004.05161.x"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2010.02.020"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01542591"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270004268128"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2008.03107.x"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2009.03404.x"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.2174\/138161209789206971"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1497.1998.00050.x"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijir.3901441"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2005.00173.x"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijir.3901258"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijir.3900567"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2011.02268.x"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(02)02102-7"},{"key":"e_1_2_8_22_1","first-page":"267","article-title":"Sildenafil or vardenafil nonresponders\u2019 erectile response to tadalafil","volume":"6","author":"Ozgur BC","year":"2009","journal-title":"Urol J"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2007.00723.x"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2009.01456.x"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2010.01817.x"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2005.20355.x"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2008.00935.x"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(97)00238-0"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijir.3900857"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2011.07.053"},{"key":"e_1_2_8_31_1","first-page":"661","article-title":"Udenafil, a long\u2010acting PDE5 inhibitor for erectile dysfunction","volume":"7","author":"Salem EA","year":"2006","journal-title":"Curr Opin Investig Drugs"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/clc.4960271305"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.10482"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2009.04.026"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2011.03.025"}],"container-title":["Andrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.2047-2927.2013.00085.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.2047-2927.2013.00085.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T09:55:31Z","timestamp":1698659731000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.2047-2927.2013.00085.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,19]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["10.1111\/j.2047-2927.2013.00085.x"],"URL":"https:\/\/doi.org\/10.1111\/j.2047-2927.2013.00085.x","archive":["Portico"],"relation":{},"ISSN":["2047-2919","2047-2927"],"issn-type":[{"value":"2047-2919","type":"print"},{"value":"2047-2927","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,19]]},"assertion":[{"value":"2012-08-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-03-01","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-06-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}